SB
WX

Suntrust Banks’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Suntrust Banks’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,858
Closed -$389K – 1471
2014
Q2 		$389K Sell
11,858
-13,399
-53% -$459K ﹤0.01% 1104
2014
Q1 		$930K Sell
25,257
-397
-2% -$14.6K ﹤0.01% 999
2013
Q4 		$984K Buy
+25,654
New +$810K ﹤0.01% 939

Other funds holding WX

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Suntrust Banks's WX Position: Q3 2014 in Review

Suntrust Banks sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2014, closing a stake of 11,858 shares — an estimated $389K sold.

Suntrust Banks first reported a position in WX in Q4 2013 and held it in 3 quarters. The position peaked at $984K in Q4 2013. 157 funds tracked by Wall St. Rank hold WX as of Q3 2014.

  • Suntrust Banks reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2014 after selling out during the quarter.
  • Suntrust Banks sold 11,858 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2014, an estimated $389K.
  • Suntrust Banks first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 3 quarters.
  • Suntrust Banks's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $984K in Q4 2013.
  • 157 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2014.

Based on Suntrust Banks's 13F filing for Q3 2014, filed 14 Nov 2014.